ArticleBMC medical imaging2026
Advancing precision risk stratification in adult diffuse gliomas through DSC-MRI-based habitat analysis.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesDiffuse gliomas exhibit substantial molecular and spatial heterogeneity. This study aimed to evaluate the ability of habitat-based radiomics models derived from dynamic susceptibility contrast MRI (DSC-MRI) and conventional MRI to identify aggressive diffuse glioma phenotypes associated with integrated histologic-molecular risk.
methodsThis retrospective study included 197 adult patients with histopathologically confirmed diffuse gliomas. Multiparametric MRI data were preprocessed and segmented into tumor and peritumoral edema. K-means clustering was used to identify imaging-defined habitats reflecting spatial hemodynamic heterogeneity. A total of 855 radiomic features were extracted from each habitat and reduced through a sequential selection process involving univariate statistical testing, correlation filtering, recursive feature elimination, and LASSO regression. Random forest classifiers were developed to predict high-risk molecular subtypes, including IDH wildtype and other aggressive genetic alterations, and validated in internal held-out testing cohort.
resultsHabitat-based models significantly outperformed whole-region analyses (AUC 0.949 (0.858, 0.989) vs. 0.931(0.833, 0.980), p = 0.013). Crucially, models derived from hemodynamic features (CBF + MTT) demonstrated superior predictive accuracy compared to conventional anatomical sequences (T1C+T2FLAIR) in both tumor (AUC 0.944 (0.852, 0.987) vs. 0.895 (0.787, 0.960)) and edema habitats (AUC 0.932 (0.835, 0.981) vs. 0.819(0.698, 0.907)). The optimal model relied solely on hemodynamic features from combined habitats (AUC 0.949 (0.858, 0.989)). Multimodal fusion failed to improve performance, suggesting that hemodynamic parameters may provide the most discriminative imaging information.
conclusionDSC-MRI-based habitat analysis provides significant value over conventional imaging by resolving perfusion heterogeneity. These findings highlight that hemodynamic features serve as a promising tool for prediction of integrated histologic-molecular risk status of adult diffuse gliomas, potentially serving as a promising imaging biomarker for preoperative assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.